triciribine has been researched along with sirolimus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Esteva, FJ; Hortobagyi, GN; Lan, KH; Lu, CH; Mills, GB; Neal, CL; Sun, MH; Tseng, LM; Wyszomierski, SL; Yu, D | 1 |
| Chen, W; Cheng, J; Ji, X; Kong, J; Li, J; Mujahid, H; Wang, H; Yin, Y; Zhai, C; Zhang, Y | 1 |
| Kang, C; Li, L; Li, Z; Pan, X; Wang, Y; Zhou, Q | 1 |
4 other study(ies) available for triciribine and sirolimus
| Article | Year |
|---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Everolimus; Female; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms; PTEN Phosphohydrolase; Ribonucleosides; Sirolimus; Trastuzumab | 2007 |
Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque.
Topics: Animals; Atherosclerosis; Autophagy; Cells, Cultured; Chromones; Cytokines; Lipids; Macrophages, Peritoneal; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plaque, Atherosclerotic; Proto-Oncogene Proteins c-akt; Rabbits; Ribonucleosides; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2014 |
Assessment of tantalum nanoparticle-induced MC3T3-E1 proliferation and underlying mechanisms.
Topics: 3T3 Cells; Animals; Apoptosis; Biocompatible Materials; Cell Proliferation; Chromones; Gene Expression Regulation; Materials Testing; Metal Nanoparticles; Mice; Microtubule-Associated Proteins; Morpholines; Ribonucleosides; Sirolimus; Tantalum | 2021 |